Activatable fibrinolytic and anti-thrombotic proteins

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 9/68 (2006.01) C07K 7/64 (2006.01) C07K 14/315 (2006.01) C07K 14/815 (2006.01) C12N 9/48 (2006.01) C12N 9/72 (2006.01) C12N 15/62 (2006.01) C12N 15/81 (2006.01) C12N 15/85 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2069085

Proteinaceous compounds are activatable by enzymes of the clotting cascade to have fibrinolytic or clot formation inhibition activity. For example, a plasminogen analogue is activatable to plasmin by thrombin or Factor Xa. Fibrinolytic or clot formation inhibition activity is therefore directed to the site of clot formation.

Des composés protéiniques peuvent être activés par des enzymes de la cascade de coagulation de manière à exercer une activité fibrinolytique ou inhibitrice de coagulation. Par exemple, un analogue de plasminogène peut être activé pour former de la plasmine au moyen de la thrombine ou le facteur Xa. L'activité fibrinolytique ou inhibitrice de coagulation est donc dirigée au site de coagulation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Activatable fibrinolytic and anti-thrombotic proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Activatable fibrinolytic and anti-thrombotic proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Activatable fibrinolytic and anti-thrombotic proteins will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1733602

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.